Using AI scans to predict bladder cancer treatment results
Part of Cancer, Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial uses an artificial intelligence model to analyze CT scans taken before bladder removal surgery. The goal is to see if the AI can predict outcomes for patients with muscle-invasive bladder cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with muscle-invasive bladder cancer confirmed by biopsy.
- You have had your bladder removed (radical cystectomy).
- You had a contrast CT scan within two weeks before your surgery.
- Your CT scan and medical records are complete.
- You did not receive chemotherapy or radiation before surgery.
- You have a type of bladder cancer called urothelial carcinoma (not other types).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a computer program to analyze your CT scans and tumor tissue slides to better predict how your bladder cancer will behave. It may help doctors give you more personalized care.
This trial uses artificial intelligence to look at ultrasound and other scans to better stage bladder cancer and predict if chemotherapy before surgery might work. It may help doctors plan your treatment more precisely.
This study tests an artificial intelligence tool designed to predict how patients will recover after bladder cancer surgery. The AI analyzes existing medical information to help doctors better understand which patients might face complications based on their other health conditions.
This study uses ultrasound with AI to better diagnose bladder masses. It's for people who have a suspicious finding on a bladder ultrasound and are already planning to have surgery to treat it.
This trial tests whether artificial intelligence (AI) can help guide surgeons during a procedure called TURBT to remove early-stage bladder cancer. The goal is to see if this technology improves the removal of cancer while potentially reducing risks.
This study tests an artificial-intelligence (AI) system during real-time bladder evaluation to better spot bladder tumors. It may help your care team find tumors more accurately during diagnosis or follow-up.
Hear when a new Bladder Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.